Gus Johnson

Board Observer at GenXComm Inc. in January 2017 to Present

Board Observer at Decisio Health, Inc. in January 2016 to Present

Advisor at Texas Innovation Center in January 2020 to Present

Board Observer at Lung Therapeutics, Inc. in January 2015 to Present

Board Observer at Astrocyte Pharmaceuticals, Inc. in January 2017 to Present

Board Observer at Alafair Biosciences, Inc. in January 2018 to Present

Board Observer at M87 in January 2017 to January 2019

Board Observer at Accordion Health, Inc. in January 2016 to January 2017

Finance and Operations Consultant at Entac Medical in January 2013 to January 2015

Director of Strategy & Operations at Sleep Science Partners in January 2009 to January 2013

Senior Associate at Hercules Capital, Inc. in January 2008 to January 2009

Associate at Bank of America Merrill Lynch in January 2007 to January 2008

Senior Corporate Development Analyst at Emergent BioSolutions in January 2006 to January 2007

Intern at Toucan Capital in January 2004 to May 2004

Intern at Cognate BioServices in January 2004 to May 2004

Vice President at Raymond James Financial Inc. in January 2000 to April 2003